Volume 82 | ESPE2014 | Next issue

ESPE 2014

Dublin, Ireland
18 Sep 2014 - 20 Sep 2014

Card image cap
Dublin, Ireland; 18-20 September 2014. Further information

Free Communications

Growth promoting therapies

Genetic Markers of Insulin Resistance are Associated with GH Response in Short SGA Children: the North European SGA Study
aDepartment of Pediatrics, Institute of Metabolic Science, University of Cambridge, Cambridge, UK; bDepartment of Growth and Reproduction, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; cMRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, UK; dDepartment of Endocrinology, Birmingham Children’s Hospital, Birmingham, UK; eDepartment of Endocrinology, Royal Hospital for Sick Children, Glasgow, UK; fDepartment of Clinical Sciences, Endocrine and Diabetes Unit, University of Lund, Lund, Sweden; gPediatric Endocrinology Unit, Department of Women’s and Children’s Health, Karolinska Institutet and University Hospital, Stockholm, Sweden; hDepartment of Pediatrics, The National Children’s Hospital, University of Dublin, Trinity College, Dublin, Ireland
hrp0082fc7.1
Gene Expression Networks Associated with Changes in Serum Markers of Metabolism and Growth in GH-Treated Children with GH Deficiency
aRoyal Manchester Children’s Hospital, Manchester, UK; bDépartement de Pédiatrie, Université Claude Bernard, Lyon, France
hrp0082fc7.3
A Decade of Clinical Experience in a Swedish University Centre Using Prediction Models to Optimize GH Treatment in Prepubertal Children
Department of Pediatrics, Göteborg Pediatric Growth Research Centre, The University of Gothenburg, Gothenburg, Sweden
hrp0082fc7.4
Impact of GH on Adult Bone Quality in Turner Syndrome: a High Resolution Peripheral Quantitative Computed Tomography Study
aDepartment of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan, Canada; bFaculty of Medicine, University of Calgary, Calgary, Alberta, Canada; cDivision of Pediatric Endocrinology, Alberta Children’s Hospital, Calgary, Alberta, Canada
hrp0082fc7.5
Topicon[trade]ThermoMatrix[trade]-Mediated Passive Transdermal Delivery of Human GH (hGH) Across EpidermFT[trade] Full-Thickness Human Skin Equivalent (HSE): Towards an Extended-Wear hGH Patch
aPrometheon Pharma, LLC, Alachua, Florida, USA; bSid Martin Biotechnology Institute (University of Florida), Alachua, Florida, USA
hrp0082fc7.6